Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug

Nearly two years after winning US approval for its opioid-induced constipation drug, Japan’s Shionogi has secured the European nod for the treatment, naldemedine, in patients that have been previously treated with a laxative.